If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHaike Chemical Group Regulatory News (HAIK)

  • There is currently no data for HAIK

Exit Facility and Cancellation

19 Mar 2018 14:38

RNS Number : 1759I
HaiKe Chemical Group Ltd.
19 March 2018
 

19 March 2018

HaiKe Chemical Group Limited

("HaiKe", the "Group" or the "Company")

Exit Facility, Cancellation and Matched Bargain Facility

Exit Facility

HaiKe Chemical Group Limited, the AIM quoted (AIM: HAIK) specialty chemical business based in Shandong Province, China announces that valid acceptances have been received under the Exit Facility by Hai Yuan Trading in respect of 15,993,036 Ordinary Shares, representing 41.7 per cent. of the Company's total issued Ordinary Shares and 93.3 per cent. of the maximum 17,134,529 Ordinary Shares to which the Exit Facility applied.

The Exit Facility is now closed, and payments to accepting holders of Ordinary Shares or Depositary Interests (as applicable) are expected to be made on 22 March 2018.

Cancellation

The Company expects that the last day of dealings in the Ordinary Shares on AIM will be today, 19 March 2018, and that admission of the Ordinary Shares to trading on AIM will be cancelled at 7.00 a.m. on 20 March 2018.

The Company will also be cancelling the Depositary Interest facility following Cancellation and Depositary Interest holders will receive a share certificate for their cancelled Depositary Interest holding.

Matched Bargain Facility

Following Cancellation, the Company will become a private overseas company and the Company recognises that this will make it more difficult for Shareholders to buy and sell Ordinary Shares should they wish to do so. Therefore, as set out in Part 7 of the circular dated 16 February 2018, the Company is making arrangements for a Matched Bargain Facility to assist Shareholders to trade in the Ordinary Shares following Cancellation. The Matched Bargain Facility will be administered directly by the Company.

Under the Matched Bargain Facility, Shareholders or persons wishing to acquire or dispose of Ordinary Shares in the Company following Cancellation should contact the Company via email to dongyi@haikegroup.com, giving an indication that they are prepared to buy or sell at a specified price. In the event that the Company is able to match that indication with an opposite sell or buy instruction, the Company will contact both parties to arrange the trade.

However, in carrying out such activities, the Company will take no responsibility to match up Shareholders wishing to sell and purchase Ordinary Shares, and no responsibility in respect of the time frame in which introductions or communications (if any) are made or as to the price at which any trades might take place.

Details of the Matched Bargain Facility will also be published on the Company website at www.haikechemical.com.

 

For further information:

 

HaiKe Chemical Group +86 546 7787789

Jes Cui, Chief Financial Officer cuizhiqiang@haikegroup.com 

Yolanda Zhang, Company Secretary yolanda.zhang@haikegroup.com 

 

Stockdale Securities +44 (0) 20 7601 6100

Richard Johnson / Elhanan Lee

 

Cardew Group +44 (0) 20 7930 0777

Shan Shan Willenbrock / Joe McGregor haike@tbcardew.com 

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

Defined terms used in this announcement have the same meaning as in the Company's circular to Shareholders dated 16 February 2018.

 

If any of the above times and/or dates in this announcement change, the revised times and/or dates will be notified to Shareholders by announcement through the Regulatory Information Service.

 

All times stated in this announcement are London times unless otherwise stated.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCJLMITMBJBBRP
Date   Source Headline
20th Apr 20099:13 amRNSRe Joint Venture
1st Apr 20097:00 amRNSChange of Adviser
16th Mar 20097:00 amRNSAppointment of Chief Financial Officer
12th Nov 20081:39 pmRNSTrading Statement Replacement
11th Nov 20088:44 amRNSTrading Statement
26th Sep 20087:00 amRNSProduction Update
17th Sep 20087:00 amRNSInterim Results
8th Sep 20088:45 amRNSMajor Contract & Project Comm
8th Sep 20087:00 amRNSNotice of Results
4th Sep 20087:00 amRNSCompany Update
23rd Jul 20082:01 pmRNSTrading Statement
11th Jul 200812:57 pmRNSDirector/PDMR Shareholding
11th Jul 200812:54 pmRNSDirector/PDMR Shareholding
10th Jul 20087:00 amRNSSpeciality chemical facility
20th Jun 200811:23 amRNSTrading Statement
20th Jun 20087:14 amRNSResult of AGM
20th Jun 20087:00 amRNS1st Quarter Results
11th Jun 20082:41 pmRNSNotice of Results
23rd May 200812:34 pmRNSAnnual Report and Accounts
30th Apr 20087:01 amRNSHolding(s) in Company
7th Apr 20087:01 amRNSFinal Results
1st Apr 20087:00 amRNSNotice of Results
31st Mar 20089:27 amRNSStmnt re Share Price Movement
17th Dec 20074:38 pmRNSDirector/PDMR Shareholding
17th Dec 20079:38 amRNSDirector/PDMR Shareholding
12th Dec 200711:15 amRNSTrading Update
19th Nov 20077:00 amRNS3rd Quarter Results
2nd Nov 200710:24 amRNSTrading Statement
9th Oct 20071:00 pmRNSDirector/PDMR Shareholding
27th Sep 20072:24 pmRNSDirector/PDMR Shareholding
21st Sep 20079:43 amRNSTrading Statement
18th Sep 20079:00 amRNSTransfer of minority stake
10th Sep 20077:01 amRNSInterim Results
24th Aug 20071:53 pmRNSHolding(s) in Company
17th Aug 200711:24 amRNSAIM Rule 26
15th Aug 20071:33 pmRNSNotice of Results
20th Jun 200710:11 amRNSAGM Statement
1st Jun 200712:34 pmRNSDirector/PDMR Shareholding
30th May 20075:04 pmRNSDirector/PDMR Shareholding
24th May 20077:00 amRNS1st Quarter Results
22nd May 20077:01 amRNSShareholder Documentation
17th May 20078:43 amRNSNotice of Results
3rd Apr 20079:13 amRNSDirector/PDMR Shareholding
3rd Apr 20077:01 amRNSFinal Results
27th Mar 20073:12 pmRNSNotice of Results
15th Feb 20075:03 pmRNSHolding(s) in Company
14th Feb 20078:00 amRNSFirst Day of Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.